Íæż½ã½ã

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Korea Biomedical Review21:09
Korea JoongAng Daily05:14Cancer Treatment Biotechnology
Korea Biomedical Review22:56Brazil South America Latin America
Korea Biomedical Review23:05
The Korea Herald02:07Brazil South America Latin America
Korea Biomedical Review22:14World Economic News Biotechnology
The Korea Herald02:20
In the last 8 hours
JD Supra12:39
In the last 7 days
The Korea Herald02:07 13-Sep-24
Korea Biomedical Review22:56 12-Sep-24
In the last month
The Korea Herald01:17 11-Sep-24
JD Supra14:47 9-Sep-24
JD Supra12:44 9-Sep-24
The Korea Herald02:20 9-Sep-24
Korea Biomedical Review22:14 8-Sep-24
Korea JoongAng Daily05:14 4-Sep-24
The Korea Herald01:06 4-Sep-24
Korea Biomedical Review21:09 3-Sep-24
Korea Biomedical Review23:05 1-Sep-24
PMLiVE07:23 29-Aug-24
Korea Biomedical Review02:53 29-Aug-24
AsiaOne21:10 28-Aug-24
Pharmaceutical Technology08:09 26-Aug-24
The Korea Herald01:23 26-Aug-24
Korea Biomedical Review01:03 26-Aug-24
Business Wire (Press Release)19:00 25-Aug-24
American Journal of Managed Care10:31 25-Aug-24
Korea Biomedical Review21:39 22-Aug-24
Center for Biosimilars07:23 21-Aug-24
view more headlines
19 Sep 12:39

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.